Eight companies raised $2.1 billion this past week, capping off the US IPO market's largest quarter in five years. The week was split between tech and biotechs, including two in the biotech space that went public at valuations of more than $2.0 billion. Over 10 companies submitted initial filings, promising an active July.
This week, we also released our 2Q 2019 US Quarterly Review. 62 companies went public during the quarter and raised $25 billion, a four-year high by deal count and a five-year high by proceeds.
KKR-backed BridgeBio became the year's largest biotech IPO